Carregant...

Glycaemic Efficacy and Safety of Linagliptin compared to Basal-Bolus Insulin Regimen in Patients with Type 2 Diabetes Undergoing Non-Cardiac Surgery: A Multicenter Randomized Clinical Trial

AIMS: The use of incretin-based therapy instead of or complementary to insulin therapy is an active area of research in hospitalized patients with type 2 diabetes (T2D). We determined glycaemic efficacy and safety of linagliptin compared to basal-bolus insulin regimen in hospitalized surgical patien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Obes Metab
Autors principals: Vellanki, Priyathama, Rasouli, Neda, Baldwin, David, Alexanian, Sara, Anzola, Isabel, Urrutia, Maria, Cardona, Saumeth, Peng, Limin, Pasquel, Francisco J., Umpierrez, Guillermo E.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7231260/
https://ncbi.nlm.nih.gov/pubmed/30456796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13587
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!